Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001047469-15-001576
Filing Date
2015-03-03
Accepted
2015-03-03 16:02:31
Documents
17
Period of Report
2014-12-31

Document Format Files

Seq Description Document Type Size
1 10-K a2223253z10-k.htm 10-K 1632099
2 EX-23.1 a2223253zex-23_1.htm EX-23.1 2765
3 EX-31.1 a2223253zex-31_1.htm EX-31.1 7376
4 EX-31.2 a2223253zex-31_2.htm EX-31.2 7390
5 EX-32.1 a2223253zex-32_1.htm EX-32.1 5604
12 G579041.JPG g579041.jpg GRAPHIC 59418
13 G825746.JPG g825746.jpg GRAPHIC 50436
14 G84877.JPG g84877.jpg GRAPHIC 50092
15 G184292.JPG g184292.jpg GRAPHIC 61067
16 G193676.JPG g193676.jpg GRAPHIC 23982
17 G187531.JPG g187531.jpg GRAPHIC 50211
  Complete submission text file 0001047469-15-001576.txt   13214147

Data Files

Seq Description Document Type Size
6 EX-101.INS adms-20141231.xml EX-101.INS 2433971
7 EX-101.SCH adms-20141231.xsd EX-101.SCH 54842
8 EX-101.CAL adms-20141231_cal.xml EX-101.CAL 67216
9 EX-101.LAB adms-20141231_lab.xml EX-101.LAB 590533
10 EX-101.PRE adms-20141231_pre.xml EX-101.PRE 433395
11 EX-101.DEF adms-20141231_def.xml EX-101.DEF 205859
Mailing Address 1900 POWELL ST., SUITE 750 EMERYVILLE CA 94608
Business Address 1900 POWELL ST., SUITE 750 EMERYVILLE CA 94608 510-450-3554
Adamas Pharmaceuticals Inc (Filer) CIK: 0001328143 (see all company filings)

EIN.: 421560076 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-36399 | Film No.: 15668961
SIC: 2834 Pharmaceutical Preparations